The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. The allogeneic stem cell therapy is expected to command the largest share of the market in 2015, and the allogeneic stem cell therapy segment is expected to grow at the highest CAGR of 40% in the forecast period (2015-2020).
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Stem Cell Therapy
Market worth $330
Million in 2020.
Therapeutic Applications (CNS, CVS, GIT, Wound Healing,
Musculoskeletal, Eye, & Immune System)
Publish Date:- April 2014.
The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications
(CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline
Analysis & Global Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and
challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).
Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC on “Stem Cell Therapy
Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound
Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global
Forecasts to 2020”
Early buyers will receive 10% customization on reports.
This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to
grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.
The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous
stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented
into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS
diseases, CVS diseases, wounds and injuries, and others.
Download FREE PDF Brochure:-http://www.marketsandmarkets.com/pdfdownload.asp?id=48
A number of factors such as the increasing funding from various government and private organizations, growing
industry focus on stem cell research, and increasing global awareness about stem cell therapies through various
organizations are stimulating the research activities for stem cell therapies. Developing markets, emergence of induced
pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies
represent high growth opportunities for market players.
In 2015, North America will hold the largest share of the global stem cell therapy market. This large share is primarily
attributed to the extensive government funding and increasing fast-track approval for stem cell therapeutics by the FDA.
Moreover, development of advanced genomic methods for stem cell analysis and high number of ongoing research
activities are further fueling the growth of the stem cell therapy market in North America. However, the Asia-Pacific stem
cell therapy market is expected to grow at the highest CAGR in the forecast period, owing to factors such as increasing
regulatory support through favorable government policies, strong product pipelines, and increasing licensing activities in
Ask for Sample Report:-http://www.marketsandmarkets.com/requestsample.asp?id=48
The stem cell therapy market includes large number of players that are involved in development of stem cell therapies
of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation
(U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically
analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and
financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India